ST14 抗体 (AA 11-100)
-
- 抗原 See all ST14 抗体
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
-
抗原表位
- AA 11-100
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This ST14 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- 交叉反应
- 人
- 预测反应
- Mouse,Rat
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human Matriptase
- 亚型
- IgG
-
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (Internal Region) antibody
ST14 适用: 人, 小鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 适用: 人, 小鼠, 大鼠 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (C-Term) antibodyST14 适用: 人, 小鼠, 大鼠, Cow, 豚鼠, 马, 犬, Pig, 兔 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 适用: 人 WB, IF, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) antibodyST14 适用: 人, 小鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 298-400) antibodyST14 适用: 人 ELISA 宿主: 小鼠 Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 10-59) antibodyST14 适用: 人 WB, ELISA, IHC, IF, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 826-855), (C-Term) antibodyST14 适用: 人, 小鼠 WB, IHC (p) 宿主: 兔 Polyclonal RB2080 unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (N-Term) antibodyST14 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) (AA 566-855) antibodyST14 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- 4 °C,-20 °C
- 储存方法
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 有效期
- 12 months
-
- 抗原
- ST14 (Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14))
- 别名
- Matriptase (ST14 产品)
- 别名
- HAI antibody, MT-SP1 antibody, MTSP1 antibody, PRSS14 antibody, SNC19 antibody, TADG15 antibody, TMPRSS14 antibody, XMT-SP1 antibody, hai antibody, mt-sp1 antibody, mtsp1 antibody, prss14 antibody, snc19 antibody, st14 antibody, st14a antibody, tadg15 antibody, tmprss1 antibody, Epithin antibody, Prss14 antibody, Tmprss14 antibody, mCAP3 antibody, matriptase antibody, suppression of tumorigenicity 14 antibody, suppression of tumorigenicity 14 L homeolog antibody, suppression of tumorigenicity 14 (colon carcinoma) antibody, ST14 antibody, st14.L antibody, St14 antibody
- 背景
-
Synonyms: HAI, MTSP1, SNC19, ARCI11, MT-SP1, PRSS14, TADG15, TMPRSS14, Suppressor of tumorigenicity 14 protein, Matriptase, Membrane-type serine protease 1, Prostamin, Serine protease 14, Serine protease TADG-15, Tumor-associated differentially-expressed gene 15 protein, ST14
Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
- 基因ID
- 6768
- UniProt
- Q9Y5Y6
-
